ABSTRACT NUMBER: ESOC2026A1641 POST-COVID-19 ATRIAL FIBRILLATION: IMMUNE DYSREGULATION AND IMPLICATIONS FOR STROKE RISK Authors: Oksana Stasyshena, Oleg Sychov, Tatiana Talaieva, Oksana Stasyshena, Taisiia Getman, Olga Sribnaya, Solovyan Anna Published: 2026 ABSTRACT AbstractBackground and aimsCOVID-19 has highlighted the link between systemic inflammation and cardiovascular complications, with atrial fibrillation (AF) being associated with poor prognosis and increased cardioembolic stroke risk.MethodsThe study included 165 patients (62.5 ± 0.9 years; 47% men, 53% women). 116 patients with AF post-COVID-19 were divided into three groups: G1 (n = 36) - new-onset AF after infection; G2 (n = 25) - progression from paroxysmal to persistent or persistent to permanent AF; G3 (n = 55) - AF without changes in form. The control group (CG) - 49 patients with AF without a history of COVID-19. Lymphocyte and monocyte subpopulations in peripheral blood were analyzed using flow cytometry.ResultsComparison of NK cell parameters among the groups revealed no statistically significant differences. Patients with post-COVID AF progression (G2) had significantly lower T-helper cell levels compared to those with stable AF (G2 vs G3: 39.7 ± 1.57% vs 46.9 ± 6.0%, p < 0.05). CD3+CD8+ cytotoxic T lymphocyte levels were 67.3% higher in G2 compared to G3 (p < 0.05). B-lymphocyte levels were lower in G2 than in the control group (8.47 ± 0.60% vs 10.4 ± 0.20%, p < 0.005). The proportion of non-classical monocytes (CD14+dimCD16++) was higher in post-COVID AF patients compared to G3 (10.9 ± 0.63% vs 7.5 ± 0.40%, p < 0.001).ConclusionsPost-COVID AF is associated with immune alterations, including reduced T-helper cells, increased cytotoxic T cells, lower B-lymphocytes, and elevated non-classical monocytes, which may contribute to AF progression and adverse outcomes.Conflict of interestOksana Stasyshena:nothing to disclose